Skip to main content
. 2015 Jul 16;59(8):4982–4989. doi: 10.1128/AAC.00925-15

FIG 4.

FIG 4

Binding of FLC and VCZ to ScErg11p6×His. (a) Difference spectra demonstrating type II binding of FLC obtained by incremental additions of the drug to 1 μM ScErg11p×His. (b) Saturation curves for FLC (filled circles) and VCZ (hollow circles) fitted to the Hill equation, with ΔA plotted against azole concentration.

HHS Vulnerability Disclosure